NO20070979L - Anvendelse av N-aryldiazaspirasykliske forbindelser i behandling av avhengighet - Google Patents

Anvendelse av N-aryldiazaspirasykliske forbindelser i behandling av avhengighet

Info

Publication number: NO20070979L
Authority: NO; Norway
Prior art keywords: compounds; effective; significant; treatment; effects
Prior art date: 2004-08-20

Application number

NO20070979A

Other languages

English (en)

Norwegian (no)

Inventor

Balwinder Singh Bhatti

Jozef Klucik

Gregory J Gatto

Original Assignee

Targacept Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-08-20

Filing date

2007-02-21

Publication date

2007-03-19

2007-02-21 Application filed by Targacept Inc filed Critical Targacept Inc

2007-03-19 Publication of NO20070979L publication Critical patent/NO20070979L/no

Links

150000001875 compounds Chemical class 0.000 title abstract 8
206010012335 Dependence Diseases 0.000 title 1
VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 abstract 4
230000000694 effects Effects 0.000 abstract 4
230000002411 adverse Effects 0.000 abstract 2
229960003638 dopamine Drugs 0.000 abstract 2
230000002401 inhibitory effect Effects 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
238000002360 preparation method Methods 0.000 abstract 2
SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 abstract 1
206010057852 Nicotine dependence Diseases 0.000 abstract 1
208000008589 Obesity Diseases 0.000 abstract 1
208000025569 Tobacco Use disease Diseases 0.000 abstract 1
125000003118 aryl group Chemical group 0.000 abstract 1
230000036772 blood pressure Effects 0.000 abstract 1
206010013663 drug dependence Diseases 0.000 abstract 1
210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
125000001072 heteroaryl group Chemical group 0.000 abstract 1
125000000623 heterocyclic group Chemical group 0.000 abstract 1
239000002117 illicit drug Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
239000002207 metabolite Substances 0.000 abstract 1
229960002715 nicotine Drugs 0.000 abstract 1
SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 abstract 1
235000020824 obesity Nutrition 0.000 abstract 1
229940002612 prodrug Drugs 0.000 abstract 1
239000000651 prodrug Substances 0.000 abstract 1
230000028327 secretion Effects 0.000 abstract 1
210000002027 skeletal muscle Anatomy 0.000 abstract 1
208000011117 substance-related disease Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4747—Quinolines; Isoquinolines spiro-condensed
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Addiction (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Neurology (AREA)
Child & Adolescent Psychology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20070979A 2004-08-20 2007-02-21 Anvendelse av N-aryldiazaspirasykliske forbindelser i behandling av avhengighet NO20070979L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US60347904P	2004-08-20	2004-08-20
PCT/US2005/029371 WO2006023630A2 (fr)	2004-08-20	2005-08-18	Utilisation de composes diazaspiracycliques n-aryle dans le traitement de la toxicomanie

Publications (1)

Publication Number	Publication Date
NO20070979L true NO20070979L (no)	2007-03-19

Family

ID=35447974

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20070979A NO20070979L (no)	2004-08-20	2007-02-21	Anvendelse av N-aryldiazaspirasykliske forbindelser i behandling av avhengighet

Country Status (16)

Country	Link
US (1)	US20060058328A1 (fr)
EP (1)	EP1784184A2 (fr)
JP (1)	JP2008510711A (fr)
KR (1)	KR20070043008A (fr)
CN (1)	CN101022801A (fr)
AU (1)	AU2005277410B2 (fr)
BR (1)	BRPI0514509A (fr)
CA (1)	CA2575461A1 (fr)
IL (1)	IL180929A0 (fr)
MX (1)	MX2007002045A (fr)
NO (1)	NO20070979L (fr)
NZ (1)	NZ552792A (fr)
RU (1)	RU2387647C9 (fr)
UA (1)	UA92327C2 (fr)
WO (1)	WO2006023630A2 (fr)
ZA (1)	ZA200701193B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE521512C2 (sv) *	2001-06-25	2003-11-11	Niconovum Ab	Anordning för administrering av en substans till främre delen av en individs munhåla
EP1578422B1 (fr)	2002-12-20	2007-04-11	NicoNovum AB	Materiau particulaire contenant de la nicotine et de la cellulose microcrystalline chimiquement et physiquement stable
US9402809B2 (en)	2006-03-16	2016-08-02	Niconovum Usa, Inc.	Snuff composition
US20080247964A1 (en) *	2006-05-08	2008-10-09	Yuelian Xu	Substituted azaspiro derivatives
WO2008096746A1 (fr) *	2007-02-06	2008-08-14	Takeda Pharmaceutical Company Limited	Composé spiro et son utilisation
AU2009205720A1 (en) *	2008-01-15	2009-07-23	Targacept, Inc.	Preparation and enantiomeric separation of 7-(3-pyridinyl)-1,7-diazaspiro[4.4] nonane and novel salt forms of the racemate and enantiomers
CN102070640A (zh) *	2009-11-24	2011-05-25	上海药明康德新药开发有限公司	一种1,7-二氮杂螺[4,5]壬烷及其衍生物的合成方法
RU2582339C2 (ru) *	2010-05-27	2016-04-27	Таргасепт, Инк.	Неконкурентные антагонисты никотиновых рецепторов
CN102267995A (zh) *	2010-06-04	2011-12-07	艾琪康医药科技（上海）有限公司	一种制备二氮杂螺环化合物的方法
CN102516146B (zh) *	2011-11-24	2013-10-02	爱斯特（成都）生物制药有限公司	5位为氮的四元氮杂螺环衍生物及其制备方法和用途
GB201416351D0 (en)	2014-09-16	2014-10-29	Shire Internat Gmbh	Heterocyclic derivatives
GB201416352D0 (en) *	2014-09-16	2014-10-29	Shire Internat Gmbh	Spirocyclic derivatives
RU2635105C1 (ru) *	2016-07-15	2017-11-09	Федеральное государственное бюджетное образовательное учреждение высшего образования "Астраханский государственный университет"	Способ получения 4-арил-2,7,9-триазаспиро[4.5]декан-6,8,10-трионов
EP3490992B1 (fr) *	2016-08-01	2023-03-22	Aptinyx Inc.	Modulateurs spiro-lactames des récepteurs nmda et leurs utilisations
CN116057045B (zh)	2020-06-05	2026-06-09	金耐特生物制药公司	成纤维细胞生长因子受体激酶抑制剂

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3282947A (en) *	1962-05-17	1966-11-01	Geschickter Fund Med Res	Unsymmetrically substituted 3, 9-diazaspiro(5, 5)undecane compounds
US4922901A (en) *	1988-09-08	1990-05-08	R. J. Reynolds Tobacco Company	Drug delivery articles utilizing electrical energy
EP0687268B1 (fr) *	1993-03-04	1998-05-27	Pfizer Inc.	Derives spiroazacycliques utilises comme antagonistes de la substance p
US5597919A (en) *	1995-01-06	1997-01-28	Dull; Gary M.	Pyrimidinyl or Pyridinyl alkenyl amine compounds
US6022868A (en) *	1995-06-29	2000-02-08	Novo Nordisk Als	Substituted azacyclic or azabicyclic compounds
US5616716A (en) *	1996-01-06	1997-04-01	Dull; Gary M.	(3-(5-ethoxypyridin)yl)-alkenyl 1 amine compounds
US5663356A (en) *	1996-04-23	1997-09-02	Ruecroft; Graham	Method for preparation of aryl substituted alefinic secondary amino compounds
US5733912A (en) *	1997-02-19	1998-03-31	Abbott Laboratories	7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission
ES2162503T3 (es) *	1998-06-12	2001-12-16	Hoffmann La Roche	Derivados diaza-espiro(3,5)nonanos.
WO2001030780A2 (fr) *	1999-10-27	2001-05-03	Cor Therapeutics, Inc.	Composes spirocycliques pyridiles inhibiteurs de l'agregation plaquettaire dependant des fibrinogenes
HUP0300413A2 (hu) *	2000-04-10	2003-06-28	Pfizer Products Inc.	Amidcsoportot viselő benzolgyűrűs csoporttal helyettesített piperidint tartalmazó és rokonszerkezetű vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
PT1519939E (pt) *	2002-07-05	2010-02-10	Targacept Inc	Compostos n-arildiazaspirocíclicos e métodos para a sua preparação e utilização

2005
- 2005-08-18 JP JP2007528005A patent/JP2008510711A/ja not_active Withdrawn
- 2005-08-18 UA UAA200702904A patent/UA92327C2/ru unknown
- 2005-08-18 NZ NZ552792A patent/NZ552792A/en not_active IP Right Cessation
- 2005-08-18 CN CNA200580031767XA patent/CN101022801A/zh active Pending
- 2005-08-18 US US11/207,102 patent/US20060058328A1/en not_active Abandoned
- 2005-08-18 CA CA002575461A patent/CA2575461A1/fr not_active Abandoned
- 2005-08-18 BR BRPI0514509-0A patent/BRPI0514509A/pt not_active IP Right Cessation
- 2005-08-18 RU RU2007110020/04A patent/RU2387647C9/ru not_active IP Right Cessation
- 2005-08-18 AU AU2005277410A patent/AU2005277410B2/en not_active Ceased
- 2005-08-18 WO PCT/US2005/029371 patent/WO2006023630A2/fr not_active Ceased
- 2005-08-18 MX MX2007002045A patent/MX2007002045A/es active IP Right Grant
- 2005-08-18 KR KR1020077003860A patent/KR20070043008A/ko not_active Ceased
- 2005-08-18 EP EP05786530A patent/EP1784184A2/fr not_active Withdrawn
2007
- 2007-01-24 IL IL180929A patent/IL180929A0/en unknown
- 2007-02-09 ZA ZA200701193A patent/ZA200701193B/xx unknown
- 2007-02-21 NO NO20070979A patent/NO20070979L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU2005277410A1 (en)	2006-03-02
WO2006023630A2 (fr)	2006-03-02
JP2008510711A (ja)	2008-04-10
UA92327C2 (ru)	2010-10-25
KR20070043008A (ko)	2007-04-24
CA2575461A1 (fr)	2006-03-02
WO2006023630A3 (fr)	2006-05-04
AU2005277410B2 (en)	2010-06-24
RU2387647C2 (ru)	2010-04-27
RU2007110020A (ru)	2008-09-27
RU2387647C9 (ru)	2011-05-27
CN101022801A (zh)	2007-08-22
NZ552792A (en)	2009-12-24
MX2007002045A (es)	2007-03-29
US20060058328A1 (en)	2006-03-16
EP1784184A2 (fr)	2007-05-16
ZA200701193B (en)	2009-09-30
IL180929A0 (en)	2007-07-24
BRPI0514509A (pt)	2008-06-10

Legal Events

Date	Code	Title	Description
2013-03-25	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
DK1519939T3 (da)	2010-04-12	N-Aryl-diazaspirocykliske forbindelser og fremgangsmåder til fremstilling og anvendelse deraf
IL295536B2 (en)	2023-08-01	Specific tryptamines for use in the treatment of mood disorders
TW200606147A (en)	2006-02-16	Indolyl derivatives as liver-X-receptor modulators
WO2006023630A3 (fr)	2006-05-04	Utilisation de composes diazaspiracycliques n-aryle dans le traitement de la toxicomanie
JP2011500506A5 (fr)	2011-06-02
NO20091251L (no)	2009-05-28	Nikotinisk acetylkolinreseptorsubtype selektive amider av diazabicykloalkaner
EA201100305A1 (ru)	2011-10-31	Лечение респираторных заболеваний
WO2002083109A1 (fr)	2002-10-24	Traitement du diabete de type 2 a l'aide d'inhibiteurs de dipeptidylpeptidase iv
AU2002244860A1 (en)	2003-04-17	Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase IV
MX2009012558A (es)	2010-04-21	Combinaciones de farmacos para el tratamiento de distrofia muscular de duchenne.
JP2007519649A5 (fr)	2008-02-28
JP2014528901A5 (fr)	2015-04-30
JP2019515908A5 (fr)	2020-06-18
NO20050569L (no)	2005-11-22	Fremgangsmate for behandling av alvorlig hjertesvikt og medikament for dette
JP2019520344A5 (fr)	2020-07-09
NO20054382L (no)	2005-09-21	Diarylsykloalkylderivater, deres fremstilling og deres anvendelse som legemiddel
MY181731A (en)	2021-01-05	Azole benzene derivative
NO20054408L (no)	2005-11-23	3(2-fenyl-oksazol-4-yl-metoksy)-cykloheksylmetoksyeddiksyrederivater og lignende forbindelser som PPAR-modulatorer for behandling av type 2 diabetes og arterosklerose
BR0306798A (pt)	2004-12-07	Uso de melagatran ou de um derivado farmaceuticamente aceitável deste, métodos de tratamento de diabetes mellitus tipo i, de transplante de células de enxertamento de ilhotas de langerhans, para melhorar a independência de insulina em pacientes com diabetes mellitus tipo i, e de tratamento de reação inflamatória mediada pelo sangue instantânea, formulação farmacêutica para uso no tratamento de diabetes mellitus tipo i, kit de partes, e, método de fabricação de um kit de partes.
NO20074661L (no)	2007-10-30	Anvendelse av en forbindelse
PT1634595E (pt)	2008-08-28	Derivados de n-fenilbenzamida como fármacos para o tratamento doença pulmonar obstativa crónica (dpoc)
EA201000739A1 (ru)	2011-02-28	Новое медицинское применение солей 3-(2,2,2-триметилгидразиниум)пропионата
CN113544121A (zh)	2021-10-22	具有β2受体激动及M受体拮抗活性的杂环衍生物及其医药用途
CN104161769B (zh)	2016-01-20	一种含环磷腺苷的组合物及其应用
MY137679A (en)	2009-02-27	2-ethoxy-3-phenylpropionic acid derivatives for the treatment of lipid disorders